🇮🇳 Alembic Pharmaceuticals Ltd

Press Release 14-11-2026 21:03:05 IST

Overview: Received USFDA final approval for its Abbreviated New Drug Application for Binimetinib Tablets, 15 mg and 45 mg, qualifying for 180 days of exclusivity.

Open document in a new tab

Get filings like this in Telegram the moment they are published — for the companies you follow.

Start 30-day trial About Finterest